Treatment with desipramine improves breathing and survival in a mouse model for Rett syndrome

European Journal of Neuroscience

Volumn 25, Issue 7, 2007, Pages 1915-1922

  Roux, Jean Christophe ^a,b   Dura, Emmanuelle ^a,b   Moncla, Anne ^a,c   Mancini, Josette ^c   Villard, Laurent ^a,b  

^a INSERM   (France)

^b AIX MARSEILLE UNIVERSITY   (France)

^c TIMONE HOSPITAL   (France)

Author keywords

Apneas; Brainstem; Noradrenaline; Norepinephrine reuptake inhibitor; Treatment

Indexed keywords

DESIPRAMINE; METHYL CPG BINDING PROTEIN 2; NORADRENALIN; PENTOBARBITAL; PLACEBO; TYROSINE 3 MONOOXYGENASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BRAIN STEM; BREATHING RATE; CELL COUNT; CELL PROLIFERATION; CONTROLLED STUDY; FEMALE; LIFESPAN; MALE; MOUSE; NONHUMAN; NORADRENALIN UPTAKE; NORADRENERGIC SYSTEM; POSTNATAL DEVELOPMENT; PRIORITY JOURNAL; PROTEIN SYNTHESIS; RETT SYNDROME; SURVIVAL RATE; SURVIVAL TIME; THERAPY EFFECT; TREATMENT OUTCOME; TREATMENT RESPONSE; WILD TYPE;

EID: 34147198993     PISSN: 0953816X     EISSN: 14609568     Source Type: Journal    
DOI: 10.1111/j.1460-9568.2007.05466.x     Document Type: Article

References (55)

1. Amir, R.E., Van den Veyver, I.B., Wan, M., Tran, C.Q., Francke, U. & Zoghbi, H.Y. (1999) Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2. Nat. Genet., 23, 185-188.
2. Armstrong, D.D. (1997) Review of Rett syndrome. J. Neuropathol. Exp. Neurol., 56, 843-849.
3. Baquet, Z.C., Bickford, P.C. & Jones, K.R. (2005) Brain-derived neurotrophic factor is required for the establishment of the proper number of dopaminergic neurons in the substantia nigra pars compacta. J. Neurosci., 25, 6251-6259.
4. Barker, E.I. & Blakely, R.D. (1995) Norepinephrine and serotonin transporters. In Kupfer, D.J. (ed.), Psychopharmacology: the Fourth Generation of Progress. Raven Press, New York, p. 321.
5. Bezin, L., Marcel, D., Desgeorges, S., Pujol, J.F. & Weissmann, D. (2000) Singular subsets of locus coeruleus neurons may recover tyrosine hydroxylase phenotype transiently expressed during development. Brain Res. Mol. Brain Res., 76, 275-281.
6. Bezin, L., Marcel, D., Rousset, C., Pujol, J.F. & Weissmann, D. (1994) Quantitative study of tyrosine hydroxylase protein levels within the somatic area of the rat locus coeruleus during postnatal development. J. Neurosci., 14, 7502-7510.
7. Bezin, L., Ortemann, C., Ogier, M., Astier, B., Pujol, J.F., Renaud, B. & Lambas-Senas, L. (2004) Enhanced tail pinch-induced activation of catecholamine metabolism in the pericerulean area of RU 24722-treated rats. Brain Res., 1030, 1-10.
8. Chang, Q., Khare, G., Dani, V., Nelson, S. & Jaenisch, R. (2006) The disease progression of Mecp2 mutant mice is affected by the level of BDNF expression. Neuron., 49, 341-348.
9. Charrier, C., Coronas, V., Fombonne, J., Roger, M., Jean, A., Krantic, S. & Moyse, E. (2006) Characterization of neural stem cells in the dorsal vagal complex of adult rat by in vivo proliferation labeling and in vitro neurosphere assay. Neuroscience., 138, 5-16.
10. Daniel, W. & Melzacka, M. (1992) A comparative study on desipramine pharmacokinetics in the rat brain after administration of desipramine or imipramine. J. Pharm. Pharmacol., 44, 429-432.
11. Dreyfus, C.F., Markey, K.A., Goldstein, M. & Black, I.B. (1983) Development of catecholaminergic phenotypic characters in the mouse locus coeruleus in vivo and in culture. Dev. Biol., 97, 48-58.
12. Dumas, S., Pequignot, J.M., Ghilini, G., Mallet, J. & Denavit-Saubie, M. (1996) Plasticity of tyrosine hydroxylase gene expression in the rat nucleus tractus solitarius after ventilatory acclimatization to hypoxia. Brain Res. Mol. Brain Res., 40, 188-194.
13. Dunn, H.G. (2001) Neurons and neuronal systems involved in the pathophysiologies of Rett syndrome. Brain Dev., 23S1, S99-S100.
14. Dunn, H.G. & MacLeod, P.M. (2001) Rett syndrome: review of biological abnormalities. Can. J. Neurol. Sci., 28, 16-29.
15. Endl, E. & Gerdes, J. (2000) The Ki-67 protein: fascinating forms and an unknown function. Exp. Cell Res., 257, 231-237.
16. Florin-Lechner, S.M., Druhan, J.P., Aston-Jones, G. & Valentino, R.J. (1996) Enhanced norepinephrine release in prefrontal cortex with burst stimulation of the locus coeruleus. Brain Res., 742, 89-97.
17. Frazer, A. (1997) Pharmacology of antidepressants. J. Clin. Psychopharmacol., 17S1, S2-S18.
18. Guo, H., Hellard, D.T., Huang, L. & Katz, D.M. (2005) Development of pontine noradrenergic A5 neurons requires brain-derived neurotrophic factor. Eur. J. Neurosci., 1, 2019-2023.
19. Guy, J., Hendrich, B., Holmes, M., Martin, J.E. & Bird, A. (2001) A mouse Mecp2-null mutation causes neurological symptoms that mimic Rett syndrome. Nat. Genet., 27, 322-326.
20. Hagerty, T., Fernandez, E., Lynch, K., Wang, S.S., Morgan, W.W. & Strong, R. (2001) Interaction of a glucocorticoid-responsive element with regulatory sequences in the promoter region of the mouse tyrosine hydroxylase gene. J. Neurochem., 78, 1379-1388.
21. Hebert, C., Habimana, A., Elie, R. & Reader, T.A. (2001) Effects of chronic antidepressant treatments on 5-HT & NA transporters in rat brain: an autoradiographic study. Neurochem. Int., 38, 63-74.
22. Ide, S., Itoh, M. & Goto, Y. (2005) Defect in normal developmental increase of the brain biogenic amine concentrations in the mecp2-null mouse. Neurosci. Lett., 386, 14-17.
23. Invernizzi, R.W. & Garattini, S. (2004) Role of presynaptic alpha2-adrenoceptors in antidepressant action: recent findings from microdialysis studies. Prog. Neuropsychopharmacol. Biol. Psychiatry, 28, 819-827.
24. Jacobsen, J.P. & Mork, A. (2004) The effect of escitalopram, desipramine, electroconvulsive seizures and lithium on brain-derived neurotrophic factor mRNA and protein expression in the rat brain and the correlation to 5-HT and 5-HIAA levels. Brain Res., 1024, 183-192.
25. Juan, G., Traganos, F., James, W.M., Ray, J.M., Roberge, M., Sauve, D.M., Anderson, H. & Darzynkiewicz, Z. (1998) Histone H3 phosphorylation and expression of cyclins A and B1 measured in individual cells during their progression through G2 and mitosis. Cytometry, 32, 71-77.
26. Julu, P.O., Kerr, A.M., Apartopoulos, F., Al-Rawas, S., Engerstrom, I.W., Engerstrom, L., Jamal, G.A. & Hansen, S. (2001) Characterisation of breathing and associated central autonomic dysfunction in the Rett disorder. Arch. Dis. Child., 85, 29-37.
27. Kerr, A.M., Armstrong, D.D., Prescott, R.J., Doyle, D. & Kearney, D.L. (1997) Rett syndrome: analysis of deaths in the British survey. Eur. Child. Adolesc. Psychiatry, 6, 71-74.
28. Kerr, A.M. & Julu, P.O. (1999) Recent insights into hyperventilation from the study of Rett syndrome. Arch. Dis. Child., 80, 384-387.
29. Komitova, M., Mattsson, B., Johansson, B.B. & Eriksson, P.S. (2005) Enriched environment increases neural stem?progenitor cell proliferation and neurogenesis in the subventricular zone of stroke-lesioned adult rats. Stroke, 36, 1278-1282.
30. L'Heureux, R., Dennis, T., Curet, O. & Scatton, B. (1986) Measurement of endogenous noradrenaline release in the rat cerebral cortex in vivo by transcortical dialysis: effects of drugs affecting noradrenergic transmission. J. Neurochem., 46, 1794-1801.
31. Lauder, J.M. & Bloom, F.E. (1974) Ontogeny of monoamine neurons in the locus coeruleus, Raphe nuclei and substantia nigra of the rat. I. Cell differentiation. J. Comp. Neurol., 155, 469-481.
32. Laurvick, C.L., de Klerk, N., Bower, C., Christodoulou, J., Ravine, D., Ellaway, C., Williamson, S. & Leonard, H. (2006) Rett syndrome in Australia: a review of the epidemiology. J. Pediatr., 148, 347-352.
33. Lekman, A., Witt-Engerstrom, I., Holmberg, B., Percy, A., Svennerholm, L. & Hagberg, B. (1990) CSF and urine biogenic amine metabolites in Rett syndrome. Clin. Genet., 37, 173-178.
34. Lorang, D., Amara, S.G. & Simerly, R.B. (1994) Cell-type-specific expression of catecholamine transporters in the rat brain. J. Neurosci., 14, 4903-4914.
35. Marcel, D., Raison, S., Bezin, L., Pujol, J.F. & Weissmann, D. (1998) Plasticity of tyrosine hydroxylase gene expression within BALB?C and C57Black?6 mouse locus coeruleus. Neurosci. Lett., 242, 77-80.
36. Nibuya, M., Morinobu, S. & Duman, R.S. (1995) Regulation of BDNF and trkB mRNA in rat brain by chronic electroconvulsive seizure and antidepressant drug treatments. J. Neurosci., 15, 7539-7547.
37. Nielsen, J.B., Lou, H.C. & Andresen, J. (1990) Biochemical and clinical effects of tyrosine and tryptophan in the Rett syndrome. Brain Dev., 12, 143-147.
38. Nomura, Y., Segawa, M. & Higurashi, M. (1985) Rett syndrome - an early catecholamine and indolamine deficient disorder ? Brain Dev., 7, 334-341.
39. Nuber, U.A., Kriaucionis, S., Roloff, T.C., Guy, J., Selfridge, J., Steinhoff, C., Schulz, R., Lipkowitz, B., Ropers, H.H., Holmes, M.C. & Bird, A. (2005) Up-regulation of glucocorticoid-regulated genes in a mouse model of Rett syndrome. Hum. Mol. Genet., 14, 2247-2256.
40. Owens, M.J., Morgan, W.N., Plott, S.J. & Nemeroff, C.B. (1997) Neurotransmitter receptor and transporter binding profile of antidepressants and their metabolites. J. Pharmacol. Exp. Ther., 283, 1305-1322.
41. Pariante, C.M., Makoff, A., Lovestone, S., Feroli, S., Heyden, A., Miller, A.H. & Kerwin, R.W. (2001) Antidepressants enhance glucocorticoid receptor function in vitro by modulating the membrane steroid transporters. Br. J. Pharmacol., 134, 1335-1343.
42. Philippe, C., Villard, L., De Roux, N., Raynaud, M., Bonnefond, J.P., Pasquier, L., Lesca, G., Mancini, J., Jonveaux, P., Moncla, A., Chelly, J. & Bienvenu, T. (2006) Spectrum and distribution of MECP2 mutations in 424 Rett syndrome patients: a molecular update. Eur. J. Med. Genet., 49, 9-18.
43. Richelson, E. (2001) Pharmacology of antidepressants. Mayo Clin. Proc., 76, 511-527.
44. Robinson, G.B., Fluharty, S.J., Zigmond, M.J., Sclabassi, R.J. & Berger, T.W. (1993) Recovery of hippocampal dentate granule cell responsiveness to entorhinal cortical input following norepinephrine depletion. Brain Res., 614, 21-28.
45. Roux, J.C., Mamet, J., Perrin, D., Peyronnet, J., Royer, C., Cottet-Emard, J.M., Pequignot, J.M. & Dalmaz, Y. (2003) Neurochemical development of the brainstem catecholaminergic cell groups in rat. J. Neural Transm., 110, 51-65.
46. Roux, J.C., Peyronnet, J., Pascual, O., Dalmaz, Y. & Pequignot, J.M. (2000) Ventilatory and central neurochemical reorganisation of O2 chemoreflex after carotid sinus nerve transection in rat. J. Physiol. (Lond.), 522, 493-501.
47. Sacchetti, G., Bernini, M., Gobbi, M., Parini, S., Pirona, L., Mennini, T. & Samanin, R. (2001) Chronic treatment with desipramine facilitates its effect on extracellular noradrenaline in the rat hippocampus: studies on the role of presynaptic alpha2-adrenoceptors. Naunyn Schmiedebergs Arch. Pharmacol., 363, 66-72.
48. Sanchez, C. & Hyttel, J. (1999) Comparison of the effects of antidepressants and their metabolites on reuptake of biogenic amines and on receptor binding. Cell. Mol. Neurobiol., 19, 467-489.
49. Segawa, M. (1997) Pathophysiology of Rett syndrome from the standpoint of early catecholamine disturbance. Eur. Child Adolesc. Psychiatry, 6S1, 56-60.
50. Shahbazian, M.D. & Zoghbi, H.Y. (2002) Rett syndrome and MeCP2: linking epigenetics and neuronal function. Am. J. Hum. Genet., 71, 1259-1272.
51. Viemari, J.C., Roux, J.C., Tryba, A.K., Saywell, V., Burnet, H., Pena, F., Zanella, S., Bevengut, M., Barthelemy-Requin, M., Herzing, L.B., Moncla, A., Mancini, J., Ramirez, J.M., Villard, L. & Hilaire, G. (2005) Mecp2 deficiency disrupts norepinephrine and respiratory systems in mice. J. Neurosci., 25, 11521-11530.
52. Vinet, J., Carra, S., Blom, J.M., Brunello, N., Barden, N. & Tascedda, F. (2004) Chronic treatment with desipramine and fluoxetine modulate BDNF, CaMKKalpha and CaMKKbeta mRNA levels in the hippocampus of transgenic mice expressing antisense RNA against the glucocorticoid receptor. Neuropharmacology, 47, 1062-1069.
53. Weese-Mayer, D.E., Lieske, S.P., Boothby, C.M., Kenny, A.S., Bennett, H.L., Silvestri, J.M. & Ramirez, J.M. (2006) Autonomic nervous system dysregulation: breathing and heart rate perturbation during wakefulness in young girls with Rett syndrome. Pediatr. Res., 60, 443-449.
54. Westfall, T.C. (1977) Local regulation of adrenergic neurotransmission. Physiol. Rev., 57, 659-728.
55. Zoghbi, H.Y. (2005) MeCP2 dysfunction in humans and mice. J. Child Neurol., 20, 736-740.